266 related articles for article (PubMed ID: 9296497)
1. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.
Somasundaram K; Zhang H; Zeng YX; Houvras Y; Peng Y; Zhang H; Wu GS; Licht JD; Weber BL; El-Deiry WS
Nature; 1997 Sep; 389(6647):187-90. PubMed ID: 9296497
[TBL] [Abstract][Full Text] [Related]
2. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 physically associates with p53 and stimulates its transcriptional activity.
Zhang H; Somasundaram K; Peng Y; Tian H; Zhang H; Bi D; Weber BL; El-Deiry WS
Oncogene; 1998 Apr; 16(13):1713-21. PubMed ID: 9582019
[TBL] [Abstract][Full Text] [Related]
4. The functions of the cdk-cyclin kinase inhibitor p21WAF1.
Boulaire J; Fotedar A; Fotedar R
Pathol Biol (Paris); 2000 Apr; 48(3):190-202. PubMed ID: 10858953
[TBL] [Abstract][Full Text] [Related]
5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
Randrianarison V; Marot D; Foray N; Cabannes J; Méret V; Connault E; Vitrat N; Opolon P; Perricaudet M; Feunteun J
Cancer Gene Ther; 2001 Oct; 8(10):759-70. PubMed ID: 11687899
[TBL] [Abstract][Full Text] [Related]
7. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
8. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype.
Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW
Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1).
Williamson EA; Dadmanesh F; Koeffler HP
Oncogene; 2002 May; 21(20):3199-206. PubMed ID: 12082635
[TBL] [Abstract][Full Text] [Related]
10. Regulation of p21WAF1/CIP1 expression by p53-independent pathways.
Zeng YX; el-Deiry WS
Oncogene; 1996 Apr; 12(7):1557-64. PubMed ID: 8622872
[TBL] [Abstract][Full Text] [Related]
11. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
12. NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1).
Op De Beeck A; Sobczak-Thepot J; Sirma H; Bourgain F; Brechot C; Caillet-Fauquet P
J Virol; 2001 Nov; 75(22):11071-8. PubMed ID: 11602746
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression.
Bates S; Ryan KM; Phillips AC; Vousden KH
Oncogene; 1998 Oct; 17(13):1691-703. PubMed ID: 9796698
[TBL] [Abstract][Full Text] [Related]
14. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
16. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
[TBL] [Abstract][Full Text] [Related]
17. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
[TBL] [Abstract][Full Text] [Related]
18. Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.
Lu M; Arrick BA
Oncogene; 2000 Dec; 19(54):6351-60. PubMed ID: 11175350
[TBL] [Abstract][Full Text] [Related]
19. Control of E2F activity by p21Waf1/Cip1.
Delavaine L; La Thangue NB
Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892
[TBL] [Abstract][Full Text] [Related]
20. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage.
Tanaka N; Ishihara M; Lamphier MS; Nozawa H; Matsuyama T; Mak TW; Aizawa S; Tokino T; Oren M; Taniguchi T
Nature; 1996 Aug; 382(6594):816-8. PubMed ID: 8752276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
